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design of this study is a cross sectional study using secondary
data. The sampling frame will include high school students. The
method of sample selection used is the clustering sampling
method. The unit of analysis is at the individual level. The study
population is high school students. The dependent variable is
weight and independent variables are: height, diet, nutrition,
exercising, age, sex, race and self-perception. RESULTS: The
model was very representational of the study population r2 =
0.584. The statistical signiﬁcance level was 0.05 and many vari-
ables (Height, Gender, Ethnicity, Age, etc.) proved to have a
strong signiﬁcant affect on weight (Beta was also used). CON-
CLUSIONS: The limitation of the study is that the survey fails
to ask any question regarding genetic disorders that inﬂuence
excessive weight gain, obesity. This information would be
formable in trying to treat adolescents who currently suffer from
genetic disorders. Also this would provide a good estimate of the
percentage of young people (by ethnicity) who are affected.
Another survey is recommended; that ask an assortment of ques-
tions pertaining to the daily habits of adolescents, a social behav-
ioral study. The information could aid in the development of a
better behavioral treatment for children in accordance to their
life style. The Youth Risk Behavioral Survey needs to be modi-
ﬁed so that it is more inclusive. The survey should be translated
into other languages and made available for students who are
not ﬂuent in comprehending English. Non-English speaking 
children do gain weight as well.
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OBJECTIVES: The HF-ACTION trial evaluates the effectiveness
of exercise as an intervention for heart failure patients. To assess
generalizability of study ﬁndings, we included a survey of par-
ticipating site characteristics as part of the study. We hypothe-
sized that rates of Medicare managed care penetration would
inﬂuence site heart failure care strategies. METHODS: Survey
items were developed based on a literature review and clinicians’
input. Sites were divided into high- and low-penetration groups
according to their counties’ rates of Medicare managed care pen-
etration. Rates were obtained from the Centers for Medicare and
Medicaid Services, and high- and low-penetration categories
were delineated by the sample median. Simple statistics were
used to describe the sample. Wilcoxon rank-sums and ∏ 2 tests
were used to test for differences between areas of high and low
managed care penetration. RESULTS: We received 47 of 50
surveys, a response rate of 94%. We found considerable varia-
tion in the availability of certain resources between areas of low
and high managed care penetration. Institutions located in high-
penetration areas were more likely than those in low-penetration
areas to treat heart failure outpatients in geriatric clinics (100%
vs. 0%, p = 0.014), to have IV diuretics available in clinic (100%
vs. 80%, p = 0.049) and to use clinics for acute care (40% vs.
11%, p = 0.044). Availability of heart failure service (96% vs.
79%, p = 0.057), availability of nutritionist in clinic (45% 
vs. 74%, p = 0.069) and use of ER for acute care episodes (85%
vs. 61%, p = 0.095) also varied by degree of managed care pen-
etration. Use of BNP blood test did not vary signiﬁcantly in inpa-
tient (high—39% vs. low—58%, p = 0.210) or outpatient
settings (50% vs. 47%, p = 0.860). CONCLUSIONS: Our
assessment in a clinical trial setting suggests that available
resources vary by degree of managed care penetration. This 
variability should be considered when analyzing the HF-
ACTION data as it could affect patient care and outcomes.
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OBJECTIVE: Evaluating gastric bypass surgery in obese
patients. METHODS: From March 1999 to December 2002,
106 obese patients underwent gastric bypass operations by a
single surgeon in a tertiary care hospital in the Midwest. The
data is extracted from the clinical charts and evaluated statisti-
cally using SPSS software. The relationship between body mass
index (BMI) of patients, type of operation performed, operating
time, length of stay (LOS) in the hospital, presence of co-mor-
bidities and payer type are analyzed. RESULTS: Fifty-six and 51
patients underwent open and laparoscopic bypass surgeries
respectively. The mean BMI is 53.96 with minimum of 36.1 and
maximum of 85.2 with the mean overall LOS being 4.22 days
with minimum of 2 and maximum 28 days. The mean LOS for
open and laparoscopic gastric bypass surgery is 5 and 3 days
respectively. The mean operating time for the open and laparo-
scopic methods are 165 and 175 minutes respectively. LOS is
positively correlated with BMI (p < 0 .05, r = 0.248), the number
of pre-existing medical conditions (p < 0.05, r = 0.218), open
surgery (p < 0.01, r = 0.323) but negatively correlated with
laparoscopic surgery (p < 0.01, r = -0.306) while intensive care
usage is positively correlated with BMI and open surgery (p <
0.01, r = 0.350 and 0.250) but is negatively correlated with
laparoscopic procedures (p < 0.01, r = -0.266). Pulse rates
greater than 110/minute on second and third post-operative days
is associated with total operating time (p < 0.01, r = 0.370) and
with post-operative leak from anastomosis on ﬁrst and third
post-operative days (p < 0.05 and 0.01, r = 0.228 and 0.272)
respectively. BMI is also positively associated with public 
aid patients but is negatively associated with private payers.
CONCLUSION: Being an increasingly popular surgery for 
obese people, gastric bypass procedures need to be carefully 
evaluated long-term for optimum clinical and economic out-
comes in view of the above ﬁndings.
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OBJECTIVE: Beta-blocker utilization in patients with mild to
moderate congestive heart failure (CHF) substantially improves
left ventricular ejection fraction and patient symptoms and
reduces overall mortality. Carvedilol and extended-release meto-
prolol succinate are the only beta-blocking agents currently indi-
cated in the US for CHF patients. Both agents have shown similar
risk reduction in overall and cause-speciﬁc mortality; however,
no comparative outcomes data for the two agents are available.
This study identiﬁes current utilization patterns (agent/dosing
regimens) of beta-blocker therapy in the CHF population at Scott
& White Health Plan. METHODS: Health plan pharmacy
claims data were retrospectively reviewed for calendar year 2002
for beta-blocker prescribing patterns for CHF patients (identi-
ﬁed by ICD-9 codes). Speciﬁcally, pharmacy claims were evalu-
ated for inclusion of beta-blockers as standard therapy for CHF,
use of FDA-approved versus off-label use of beta-blockers for
CHF, and use of recommended doses. RESULTS: Approximately
1700 health plan CHF patients were identiﬁed; 40% of those
